Thursday, 13 December 2018
Latest news
Main » Horizon Pharma PLC (NASDAQ:HZNP) Receives Hold Rating from Mizuho

Horizon Pharma PLC (NASDAQ:HZNP) Receives Hold Rating from Mizuho

07 September 2017

MidSouth Bancorp, Inc. (NYSE:MSL) has risen 37.43% since September 6, 2016 and is uptrending. It has outperformed by 3.44% the S&P500.

Broadfin Capital Llc decreased Horizon Pharma Plc (Call) (HZNP) stake by 23.81% reported in 2016Q4 SEC filing. Janus Capital Management LLC now owns 4,409,717 shares of the biopharmaceutical company's stock worth $65,173,000 after purchasing an additional 717,643 shares during the last quarter. Highbridge Capital Management LLC now owns 1,545,169 shares of the biopharmaceutical company's stock worth $22,837,000 after buying an additional 867,927 shares during the last quarter.

Horizon Pharma Public Limited Company, launched on December 20, 2011, is a biopharmaceutical company. The stock was last seen -0.44% lower, reaching at $13.62 on Sep. About 1.58 million shares traded. It has underperformed by 44.83% the S&P500.

Investors sentiment decreased to 1.02 in Q4 2016. Next quarter's EPS is expected be $0.23 with next year's EPS projected to be $1.26. It dropped, as 40 investors sold HZNP shares while 69 reduced holdings. 44 funds opened positions while 67 raised stakes. The biopharmaceutical company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.29. Profund Advsrs Ltd Llc stated it has 0.01% of its portfolio in Horizon Pharma PLC (NASDAQ:HZNP). California Pub Employees Retirement Sys, California-based fund reported 314,200 shares. BlackRock Inc. increased its stake in Horizon Pharma PLC by 68,479.5% in the first quarter. Royal Bancorporation Of Canada reported 657,331 shares or 0.01% of all its holdings. Moreover, Hodges Management has 1.62% invested in Horizon Pharma PLC (NASDAQ:HZNP) for 2.18 million shares. Eagle Ridge Investment Management holds 0.06% of its portfolio in UFP Technologies, Inc. Its up 0.13, from 0.87 in 2016Q3. Morgan Stanley reported 0% stake. Menta Lc reported 83,309 shares. Blackrock Ltd Liability stated it has 262,037 shares. Bank of Montreal Can grew its holdings in shares of Horizon Pharma PLC by 16.3% in the second quarter. Balasa Dinverno & Foltz Limited Liability Corporation has 0.14% invested in Horizon Pharma PLC (NASDAQ:HZNP) for 50,000 shares. 10,000 were reported by Edge Wealth Ltd Liability.

Since June 8, 2017, it had 12 insider purchases, and 0 insider sales for $357,996 activity. GREY MICHAEL G bought $94,800 worth of stock. Therefore 77% are positive. Mizuho reissued a "hold" rating and set a $12.00 price objective (up previously from $9.00) on shares of Horizon Pharma PLC in a research report on Monday, August 28th. The firm has "Buy" rating by UBS given on Tuesday, August 8. The firm has "Buy" rating given on Tuesday, September 13 by Mizuho. The stock has "Buy" rating by Goldman Sachs on Thursday, December 17. Horizon Pharma PLC presently has a consensus rating of "Buy" and an average target price of $19.69. The original version of this report can be accessed at Five equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. They presently have a $12.00 target price on the biopharmaceutical company's stock, up from their prior target price of $9.00. The firm has "Buy" rating given on Tuesday, July 25 by Piper Jaffray.

Capital Growth Management Lp decreased Rio Tinto Plc (NYSE:RIO) stake by 130,000 shares to 620,000 valued at $23.85M in 2016Q4. It also reduced Mallinckrodt Pub Ltd Co (NYSE:MNK) stake by 406,213 shares and now owns 1.15 million shares. Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) was reduced too.

Since March 13, 2017, it had 0 insider buys, and 4 sales for $1.50 million activity. The insider Corrales Eugenia sold $8,193. The company's shares were given away at $16.03 per share worth to an income of some $509,882 on account of Carey Robert. (NYSE:TSN) for 861,174 shares. Shoretel Inc. had 13 analyst reports since August 6, 2015 according to SRatingsIntel. As per Thursday, January 26, the company rating was initiated by Citigroup. (NYSE:MSL) has "Hold" rating given on Wednesday, June 7 by Keefe Bruyette & Woods. The rating was maintained by Wells Fargo with "Hold" on Thursday, July 27. Armistice Capital, LLC claims 820,000 shares valued at $9,733,000. Citigroup downgraded Unum Group (NYSE:UNM) on Monday, March 13 to "Neutral" rating. The stock has "Market Perform" rating by Hovde Group on Friday, May 6. The firm has "Neutral" rating by Compass Point given on Monday, November 28.

Investors sentiment increased to 2.32 in Q4 2016. Its down 0.03, from 0.87 in 2016Q3. 10 funds opened positions while 22 raised stakes. Brick & Kyle reported 400 shares. Smithfield Trust holds 0% or 300 shares. Sumitomo Mitsui Tru Inc accumulated 681,455 shares. 396 were reported by Acadian Asset Management Limited Liability Company. Putnam Invs Ltd owns 138,670 shares or 0.01% of their U.S. portfolio. Fiera Cap Corporation stated it has 1.42M shares or 0.13% of all its holdings. Naples Glob Limited Liability Company owns 21,150 shares or 0.11% of their USA portfolio. 90 were accumulated by Synovus Financial. Hap Trading Ltd reported 0.04% of its portfolio in Horizon Pharma PLC (NASDAQ:HZNP). Credit Suisse Ag holds 224,618 shares. The institutional investor owned 232,168 shares of the biopharmaceutical company's stock after purchasing an additional 28,700 shares during the quarter.